UPDATE: IFF (IFF) Said to Consider Divestitures Following Dupont Deal - Bloomberg

February 16, 2021 11:22 AM EST

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
(Updated - February 16, 2021 11:25 AM EST)

IFF (NYSE: IFF)is pursuing two divestments after completing the purchase of DuPont's nutrition and biosciences unit, according to Bloomberg, citing people with knowledge of the matter.

It is seeking a buyer for its microbial controls business, which could be valued at $1 billion to $1.5 billion.

It's also preparing to gauge interest in some food preparation assets that could fetch about $200 to $300 million.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Mergers and Acquisitions, Rumors